Vaccines
-
When will the US measles outbreak end?A public health official in Texas recently warned that the state's ongoing measles outbreak could last a year. Why are cases expected to keep rising?
By Emily Cooke Published
viruses-infections-disease -
What are cancer vaccines?Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than regular vaccines intended to prevent infectious diseases, like measles or the flu.
By Marilyn Perkins Published
cancer -
Who should get the new RSV vaccines? Here's everything you need to knowThere are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference?
By Nicoletta Lanese Last updated
medicine-drugs -
CDC issues new guidelines for RSV vaccines, citing side-effect concernsThe CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.
By Nicoletta Lanese Published
medicine-drugs -
How worried should we be about PFAS, the 'forever chemicals'?Recent studies suggest PFAS can pass through human skin and through the placenta. What does that mean for our health?
By Miriam Bergeret Published
health -
New RSV shots tied to rare nervous system disorder — should you worry?There's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But health officials still recommend that this population get the shots, in consultation with their doctors.
By Stephanie Pappas Published
medicine-drugs -
Mpox cases are far outpacing last year's numbers, CDC reportsHealth officials are encouraging people at risk of mpox to seek vaccination, as cases are on the rise.
By Nicoletta Lanese Published
viruses-infections-disease -
US has already had more measles cases in 2024 than all of 2023CDC data shows that more than 60 measles cases have been reported so far in 2024, surpassing last year's total.
By Nicoletta Lanese Published
viruses-infections-disease -
RSV vaccine keeps older adults highly protected for at least 2 seasonsPfizer's recently approved RSV vaccine maintains a high and fairly steady rate of effectiveness across consecutive RSV seasons.
By Nicoletta Lanese Published
medicine-drugs
